metabolic function News
-
Our Partnership with Cerba HealthCare
The Cerba HealthCare Group and METAFORA biosystems are to cooperate in the deployment of METAFORA proprietary technology in the field of metabolomics for diagnostics purposes. The technological platform developed by METAFORA enables the evaluation of cells’ energy needs in connection with patients’ health. “The investigation into altered metabolic functions for the ...
-
Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth
Kallyope Inc., a leading biotechnology company focused on identifying and pursuing novel therapeutics involving the gut-brain axis, today announced that the Board of Directors has appointed Jay Galeota as President and he will succeed Nancy Thornberry as Chief Executive Officer by October 1, 2021. Mr. Galeota also joins the Kallyope Board of Directors. Ms. Thornberry will remain actively involved ...
-
Exercising everyday keeps the doctor away
The health benefits of regular exercise are well known and are commonly featured in public awareness campaigns. Now, recent research has revealed just how dangerous a lack of physical activity can be to the human body. One of the most repeated pieces of medical advice given today is that people should do at least 30 minutes of moderate exercise five days a week. This regular activity is thought ...
-
CD Genomics Unveils Advanced Mitochondrial Diseases Panel Sequencing Service
CD Genomics, a leading biotechnology company specializing in genomics and sequencing, has announced the launch of its advanced Mitochondrial Diseases Panel Sequencing services. This new panel enables rapid and accurate detection of mutations in mitochondrial DNA (mtDNA) that are associated with a wide range of mitochondrial disorders. Mitochondrial diseases are a complex and heterogeneous group ...
By CD Genomics
-
Newly Discovered Cells Restore Liver Damage in Mice without Cancer Risk
The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the National Institutes of Health discovered a type of cell in mice essential to the process. The researchers also found similar cells in humans. When healthy liver cells are depleted by long-term exposure to toxic ...
-
Tissue Genesis, LLC Provides Cell Isolation Processing for Patients with Critical Limb Ischemia (CLI) in Ukrainian Clinical Study
Tissue Genesis, LLC, the leading provider of cell isolation technology is pleased to announce that the Icellator® is being used to generate therapeutic cell preparations at the V.P. Komisarenko Institute of Endocrinology and Metabolism in Kiev, Ukraine, for patients with critical limb ischemia (CLI). The autologous stem-cell therapy, which utilizes a patient’s own fat cells, is the ...
-
Why need to drink hydrogen water and where can buy hydrogen water generator
Olansi Healthcare Co., Ltd (Olansi Healthcare Co., Ltd, Guangzhou Olans Water Treatment Equipments Co., Ltd, and Guangzhou Zenfly Environmental Protection Equipment Co.,Ltd these three factory all belongs to our President Mr. Peng Wei) is a professional manufacturer of hydrogen water bottle,hydrogen water pitcher,hydrogen water maker, hydrogen water generator etc. Healthcare products. It ...
-
Why need to drink hydrogen water and where can buy hydrogen water generator
Olansi Healthcare Co., Ltd (Olansi Healthcare Co., Ltd, Guangzhou Olans Water Treatment Equipments Co., Ltd, and Guangzhou Zenfly Environmental Protection Equipment Co.,Ltd these three factory all belongs to our President Mr. Peng Wei) is a professional manufacturer of hydrogen water bottle,hydrogen water pitcher,hydrogen water maker, hydrogen water generator etc. Healthcare products. It locates ...
-
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD BioSciences, a US-based CRO serving the global life science research community, has announced the launch of its new services to study the Mechanistic Target of Rapamycin (mTOR) in diabetes and metabolism research. The mechanistic Target of Rapamycin is a serine/threonine protein kinase that is inhibited by rapamycin, a bacterial compound originally isolated from Easter Island soil that ...
-
Creative Proteomics Lipidomics Upgrades Its Medium-Chain and Long-Chain Fatty Acids Analysis Service
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomic research services for biomedical institutions as well as biotechnological and pharmaceutical companies. The company has recently upgraded its medium-chain and long-chain fatty acid analysis service. This service can provide reflections on lipid metabolism, glucose ...
-
Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process
Pronalyse is a subdivision of Creative Proteomics, an integrated CRO company with rich experience in providing drug development services. Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its fusion proteins characterization service to ensure the production of safe and effective therapeutic fusion proteins. Fusion protein refers to a new type of synthetic ...
-
MicrobioSeq Introduces Fungal Whole-Genome De Novo Sequencing Platform to Facilitate Microbial Research
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. To help scientific researchers better understand fungal biodiversity, physiology, metabolism and function, CD Genomics MicrobioSeq has launched ...
By CD Genomics
-
Creative Proteomics Lipidomics Announces Exosomes Lipidomics Service to Identify Lipid-based Biomarkers
Lipidomics, a division of Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The product manager has recently announced the fully-developed exosomes lipidomics service to help identify lipid-based biomarkers and unravel its monitoring function in diseases. ...
-
Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant
Creative Enzymes, a global leader in enzyme production, is thrilled to announce the latest addition to their hydrolase product line, the Recombinant S-Adenosyl-L-Homocysteine Hydrolase (SAHH). This announcement underscores its unwavering commitment to enzyme innovation and proven track to offering scientifically advanced products. SAHH, a crucial enzyme involved in the biological methylation ...
-
New Metabolic Biomarkers Open Door to Earlier Diagnosis, More Precise and Individualized Treatment of Children at Risk for Autism
Continued analysis of samples from the Children’s Autism Metabolome Project (CAMP), the most comprehensive clinical study of metabolism in children who have autism spectrum disorder (ASD) conducted to date, has identified three new areas of metabolism that affect the biology of children with ASD. These include biomarkers indicating that altered neurotransmission, energy metabolism, and ...
By NeuroPointDX
-
Creative Proteomics Lipidomics Launches Exosomes Lipidomics Service to Study the Biological Characteristics of Vesicles
Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population ...
-
Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology companies, and pharmaceutical companies. The company has recently announced the fully-developed untargeted lipidomics service, which can analyze hundreds of different lipids simultaneously, and is widely used ...
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Microbial Metabolomics Solutions
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. With deep industry and business process expertise and a good reputation in providing contract services specialized for metabolomics, Creative Proteomics Metabolomics announced the launch of ...
-
Lipidomics Bioinformation Analysis Now Available by Creative Proteomics’s Lipidomics Platform
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnological and pharmaceutical companies. The company has recently announced the launch of a fully-developed lipidomics bioinformation analysis service to screen differential lipid molecules and analyze their pathways, ...
-
Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy RBX2660
Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3 clinical trial for RBX2660 RBX2660 is an investigational, non-antibiotic, microbiome-based therapy, developed to reduce Clostridioides difficile (C. diff) infection recurrences CDC defines C. diff as a major burden to patients and doctors and an urgent ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you